Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Context Partners Fund, L.P. 13F Holdings -- Portfolio & Top Positions (2020-09-30)

Context Partners Fund, L.P. (CIK 1505246) reported $460.1M across 153 reported positions in its SEC 13F filing for 2020-09-30. Largest positions: EGHT ($19.4M, 4.22%), ($13.1M, 2.84%), VNE ($12.8M, 2.77%), ICPT ($12.7M, 2.76%), AMAG ($12.6M, 2.74%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1EGHT8X8 INC NEW$19.4M4.22%0New
2SEA LTD$13.1M2.84%0New
3VNEVEONEER INCORPORATED$12.8M2.77%0New
4ICPTINTERCEPT PHARMACEUTICALS IN$12.7M2.76%0Added
5AMAGAMAG PHARMACEUTICALS INC$12.6M2.74%0Added
6CCIV.UCHURCHILL CAPITAL CORP IV$11.6M2.53%890,000New
7CFIIUCF FINANCE ACQUISITION CORP$11.6M2.53%1.2MNew
8NHIQNANTHEALTH INC$11.3M2.46%0Added
9INFNINFINERA CORPORATION$10.8M2.36%0Added
10PRAAPRA GROUP INC$10.7M2.33%0New
11FLXNFLEXION THERAPEUTICS INC$10.3M2.23%0New
12NSH.UNAVSIGHT HLDGS INC$8.9M1.94%885,447New
13CKHSEACOR HOLDINGS INC$8.8M1.91%0New
14TVTXRETROPHIN INC$8.8M1.91%0New
15IQIQIYI INC$8.7M1.90%0New
16OMEROMEROS CORP$8.5M1.85%0New
17GOSSGOSSAMER BIO INC$7.4M1.61%7.2MNew
18DISHRDISH NETWORK CORP$7.4M1.60%0New
19VG2VONAGE HLDGS CORP$7.0M1.52%0New
20AGGISHARES TR$6.4M1.40%54,600New
21FIIIUFORUM MERGER III CORP$6.4M1.38%610,200New
22THERAVANCE BIOPHARMA INC$6.3M1.38%0Added
23XERSXERIS PHARMACEUTICALS INC$6.3M1.36%0New
24BILIBILIBILI INC$6.2M1.34%0New
25PSACUPROPERTY SOLUTIONS ACQUISITI$6.1M1.32%599,990New

Source: SEC Form 13F filings · as of 2020-09-30